BioSpace News Archive

StoneBridge Healthcare, LLC (StoneBridge), an innovative company formed to buy, save and turn around deeply distressed hospitals in the cities and suburbs of America, today announced it has presented a Letter of Intent (LOI) to purchase Tennessee-based Erlanger Health System.

Today, Virta Health , the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery, announced a partnership with the St. Louis Area Business Health Coalition (BHC), a non-profit organization representing over 70 forward-thinking employers that provide health benefits to

Today, the Silicon Valley Recovery Roundtable (SVRR) released the final report, “Building a Better Normal.” The report outlines a series of recommendations designed to aid Silicon Valley’s recovery from the economic fallout of the COVID-19 pandemic

Hansa Biopharma (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the European Commission has granted conditional approval for IdefirixTM in highly sensitized kidney transplants patients.

Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its first quarter fiscal year 2021 financial results on Tuesday, September 8, 2020, after the close of trading.

DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown , President, CEO, Michael H. Arenberg , Chief Financial Officer and Dr. WeiQi Lin , Executive Vice President of R&D will be participating in a fireside chat hosted by Ellie Merle of Cantor Fitzgerald, tomorrow, Thursday, August 27, 2020 at 11:00 a.m

Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ), announces that the Company will be relying on the temporary 45 day extension to the filing deadline of its interim financial statements and management’s discussion and analysis (“MD&A”) for the quarter ended June 30, 2020 granted by the Alberta Securities Commission (“ASC”) in response to unprecedented challenges resulting from COVID-19. The noti

Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), and Fio Corporation (“Fio”) announce the commencement of operations of the Fionet Rapid Response Group (“FRR”) to bring a new COVID-19 mobile testing and tracking platform to market.

A pilot study using Attune Medical’s ensoETM, a thermal regulating device, has begun enrollment in the first study to evaluate the impact of core warming on the length and severity of illness in hospitalized patients with COVID-19.

Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today provided the following “Update” on its effort to produce a Covid-19 Swift Kit antigen testing methodologies and secure FDA EUA approval for its products.